Adenosine receptors as therapeutic targets
Open accessThe DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these, A1 and A2A receptors are considered the principal targets mediating caffeine’s physiological effects.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“A key mechanism underlying the interaction between caffeine and exercise is caffeine’s pharmacological action as a competitive adenosine receptor antagonist.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“Instead, competitive blockade of A1 and A2A adenosine receptors is widely regarded as the central mechanism underlying caffeine’s physiological effects during both habitual intake and exercise (Figure 1) [28,29,30,31].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“Within the range of plasma concentrations relevant to sports nutrition practice, typically micromolar levels achieved after low-to-moderate caffeine intake, caffeine’s primary mechanism of action is unlikely to involve phosphodiesterase (PDE) inhibition or direct intracellular Ca2+ release.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“This effect modulates key physiological processes such as anti-inflammatory responses, angiogenesis, and vasodilation, as illustrated in Figure 2 (left panel) [52,66,67,68].”
From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [68]
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Self-citationCalker, D. V., Müller, M., & Hamprecht, B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05236.x · Cited by 1,371
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Adenosine: A Mediator of the Sleep-Inducing Effects of Prolonged Wakefulness
Porkka-Heiskanen, T., Strecker, R. E., Thakkar, M., Bjørkum, A. A., Greene, R. W., & McCarley, R. W. (1997) · Science · doi:10.1126/science.276.5316.1265 · Cited by 1,252
Subclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Extracellular metabolism of ATP and other nucleotides
Zimmermann, H. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000309 · Cited by 990
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Research works printed but not linked: 1
- Ji, X. D. & Jacobson, K. A. [3H]-ZM241385 as a radioligand at recombinant human A2B adenosine receptors. Drug Des. Discov. 16, 217–226 (1999).
Cited by
Items 901–1,000 of 1,001
COFFEE: A HEALTH FUEL-BLOT POPULAR DRINKING
Islam, M. T., de Alencar, M. V. O. B., Oliveira, G. A. L. D., da Mata, A. M. O. F., Silva, S. W. C., Paz, M. F. C. J., & Cavalcante, A. A. D. C. M. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 12
Załuski, M., Stanuch, K., Karcz, T. P., Hinz, S., Latacz, G., Szymańska, E., Schabikowski, J., Doroż-Płonka, A., Handzlik, J., Drabczyńska, A., et al. (2018) · MedChemComm · doi:10.1039/c8md00070k · Cited by 12
Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation
Rothe, R., Schulze, S., Neuber, C., Hauser, S., Rammelt, S., & Pietzsch, J. (2019) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-199104 · Cited by 12
“Associated vascularization after administration of A 2 AR agonists demonstrably supports wound healing [37, 41, 46, 55].”
Lyapustin, D. N., Ulomsky, E. N., Zanakhov, T. O., & Русинов, В. Л. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.9b02286 · Cited by 12
Bao, Q., Ganbold, T., Qiburi, Q., Bao, M., Han, S., & Baigude, H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.138 · Cited by 12
Fasting activated histaminergic neurons and enhanced arousal effect of caffeine in mice
Wang, Y., Li, R., Wu, X., Fen, Z., Takata, Y., Zhang, Z., Zhang, M., Li, S., & Qu, W. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.04.003 · Cited by 11
Harvey, A. L., Young, L., Kornisiuk, E. E., Snitcofsky, M., Colettis, N. C., Blanco, C., Jerusalinsky, D. A., Jamieson, A. G., Hartley, R. C., & Stone, T. W. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.06.023 · Cited by 11
Cheong, S. L., Dolzhenko, A. V., Paoletta, S., Lee, E. P. R., Kachler, S., Federico, S., Klotz, K., Dolzhenko, A. V., Spalluto, G., Moro, S., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.026 · Cited by 12
Yaziji, V., Rodriguez, D. J., Coelho, A., Xerardo Garcia-mera, B., Maatougui, A. E., Brea, J. M., Loza, M. I., Cadavid, M. I., Gutiérrez‐de‐Terán, H., & Sotelo, E. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.11.010 · Cited by 12
Das, A., Sanjayan, G. J., Kecskés, M., Yoo, L. S., Gao, Z., & Jacobson, K. A. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-11 · Cited by 12
“Radioligand binding assays were performed on three subtypes of ARs, following the procedure described previously [36].”
MethodInfluentialSelf-citationАденозиновый рецептор A2Aкак лекарственная мишень для терапии сепсиса
Сивак, К. В., Vasin, A. V., Egorov, V. V., Цветков, В. Б., Kuzmich, N. N., Savina, V. A., Киселев, О. И., Sivak, K. V., Vasin, А. V., Egorov, V. V., et al. (2016) · Molecular Biology · doi:10.7868/s0026898416020233 · Cited by 12
Effect of Polydeoxyribonucleotide Injection in a Patient With Carpal Tunnel Syndrome
Park, J., & Park, D. (2018) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000901 · Cited by 12
Beste, A., Taylor, D. E., Shih, T., & Thomas, T. P. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.04.017 · Cited by 12
Signaling by adenosine receptors—Homeostatic or allostatic control?
Cunha, R. A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000213 · Cited by 14
Wolska, N., Boncler, M. A., Polak, D., Wzorek, J., Przygodzki, T., Gapińska, M., Watała, C. W., & Różalski, M. (2019) · Molecules · doi:10.3390/molecules25010130 · Cited by 13
“When compared to adenosine, this non-selective AR agonist, exhibiting high affinity at A1 (Ki = 14 nM), A2A (Ki = 20 nM) and A3 (Ki = 25 nM) adenosine receptors and lower affinity at A2B AR (EC50 = 140 nM), was shown to be over 20,000 times more potent as a vasodilator and 5-10 more effective as an inhibitor of platel…”
BackgroundInfluentialYoo, J. I., Daugherty, P. S., & O’Malley, M. (2020) · Nature Communications · doi:10.1038/s41467-020-14495-7 · Cited by 12
In Vivo Positron Emission Tomography Imaging of Adenosine A2A Receptors
Sun, M.-J., Liu, F., Zhao, Y., & Wu, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.599857 · Cited by 12
“It is known that cytoprotective and neuromodulatory function in the brain are mediated by four adenosine receptors (ARs), namely A1, A2A, A2B, and A3 (Jacobson and Gao, 2006; Khanapur et al., 2013).”
BackgroundTiming Effect of Adenosine-Directed Immunomodulation on Mouse Experimental Autoimmune Uveitis
Ko, M. K., Shao, H., Kaplan, H. J., & Sun, D. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100182 · Cited by 12
“Such findings have inspired attempts to treat immune dysfunction by targeting adenosine receptors (AR) (11, 12, 14, 15).”
BackgroundAn efficient convergent synthesis of adenosine-5′-N-alkyluronamides
Devine, S. M., & Scammells, P. J. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.11.100 · Cited by 12
The movers and shakers of deep brain stimulation
Asaad, W. F., & Eskandar, E. N. (2008) · Nature Medicine · doi:10.1038/nm0108-17 · Cited by 12
Romagnoli, R., Baraldi, P. G., Carriòn, M. D., Cruz‐López, O., Lopez-Cara, L. C., Saponaro, G., Preti, D., Tabrizi, M. A., Baraldi, S., Moorman, A. R., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.043 · Cited by 12
Talme, T., Bergdahl, E., & Sundqvist, K. (2016) · European Journal of Immunology · doi:10.1002/eji.201546122 · Cited by 12
Zhang, Y., Tuft, R. A., Lifshitz, L. M., Fogarty, K. E., Singer, J. J., & Zou, H. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00032.2007 · Cited by 12
“Since the affinity of caffeine for adenosine receptors is in the micromolar range (17), 200 M caffeine should have caused a maximum response.”
BackgroundThe Hydrazine Moiety in the Synthesis of Modified Nucleosides and Nucleotides
Guillou, A., Peyrottes, S., Vasseur, J., Mathé, C., & Smietana, M. (2024) · ChemMedChem · doi:10.1002/cmdc.202400234 · Cited by 11
Adenosine transmission from hypothalamic tanycytes to AGRP/NPY neurons regulates energy homeostasis
Kim, N., Kim, S., Park, S., & Kim, E. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01449-6 · Cited by 13
Yuan, G., Jankins, T. C., Patrick, C. G., Philbrook, P., Sears, O., Hatfield, S. M., Sitkovsky, M. V., Vasdev, N., Liang, S. H., Ondrechen, M. J., et al. (2017) · International Journal of Medicinal Chemistry · doi:10.1155/2017/4852537 · Cited by 11
“Introduction The adenosine receptors belong to the G protein-coupled receptor (GPCR) family including A1, A2A, A2B, and A3, four subtypes based on their different subcellular localization, signal transduction pathways, activation profiles, ligand binding profiles, and G protein binding preferences [1, 2].”
Mieczkowski, A., Kierozalska, A., Białek‐Pietras, M., Goszczyński, T. M., Janczak, S., Olejniczak, A. B., Studzińska, M., Paradowska, E., & Lesnikowski, Z. J. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0517 · Cited by 11
Therapeutic Potentials of Adenosine Receptors: The State of The Art
Deb, P. K. (2019) · Current Pharmaceutical Design · doi:10.2174/138161282526191007143942 · Cited by 11
Purinergic signalling in the cardiovascular system—a tribute to Geoffrey Burnstock
Ralevic, V. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09734-x · Cited by 15
Application of diazonium chemistry in purine modifications: A focused review
Sengupta, S., & Das, P. (2021) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4352 · Cited by 11
Thuraiaiyah, J., Kokoti, L., Al‐Karagholi, M. A., & Ashina, M. (2022) · Cephalalgia · doi:10.1177/03331024221077665 · Cited by 11
“Gbc subunits Activates PLC and upregulates IP3 (4,5).”
BackgroundInfluentialA2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable?
Spinaci, A., Lambertucci, C., Buccioni, M., Ben, D. D., Graiff, C., Barbalace, M. C., Hrelia, S., Angeloni, C., Tayebati, S. K., Ubaldi, M., et al. (2022) · Molecules · doi:10.3390/molecules27082386 · Cited by 13
“ZM241385 (4) pHO-Ph(CH2)2NH 2-Furyl 774 [38] 1.”
Connexin and Pannexin Large-Pore Channels in Microcirculation and Neurovascular Coupling Function
Burboa, P. C., Puebla, M., Gaete, P. S., Durán, W. N., & Lillo, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137303 · Cited by 12
Bonfili, P., Franzese, P., Marampon, F., Verghetta, M. E. L., Parente, S., Cerasani, M., Genova, D. D., Mancini, M., Vittorini, F., Gravina, G. L., et al. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-2051-9 · Cited by 13
“It has been suggested that adenosine regulates inflammation via interaction with one or more of its four known receptors (A1, A2A, A2B, and A3) [6, 7].”
Backgroundde Matsumoto, J. P. P., de Almeida, M. G., Castilho-Martins, E. A., Costa, M. A., & Fior-Chadi, D. R. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.05.007 · Cited by 17
The Use of Adenosine in Cerebral Aneurysm Clipping: A Review
Khan, S. A., Nimjee, S. M., Guinn, N. N., Zomorodi, A. R., Lam, A. M., Britz, G. W., & McDonagh, D. L. (2013) · Current anesthesiology reports · doi:10.1007/s40140-013-0018-5 · Cited by 11
Bedford, S. T., Benwell, K. R., Brooks, T., Chen, I., Comer, M., Dugdale, S., Haymes, T., Jordan, A. M., Kennett, G. A., Knight, A. R., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.040 · Cited by 11
Towards Next Generation Adenosine A2A Receptor Antagonists
Yuan, G., & Jones, G. B. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140826115123 · Cited by 11
Could Adenosine Recognize its Receptors with a Stoichiometry Other than 1 : 1?
Deganutti, G., Salmaso, V., & Moro, S. (2018) · Molecular Informatics · doi:10.1002/minf.201800009 · Cited by 11
Peptide-Liganded G Protein-Coupled Receptors as Neurotherapeutics
Eiden, L. E., Goosens, K. A., Jacobson, K. A., Leggio, L., & Zhang, L. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00017 · Cited by 12
Self-citationSimvastatin attenuates acute lung injury by activation of A2B adenosine receptor
Li, H., Liang, X., Wu, J., Yuan, Y., Gao, Y., & Cai, S. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115460 · Cited by 11
Francisco, C. M., Fischer, L. W., Vendramini, V., de Oliva, S. U., Paccola, C. C., & Miraglia, S. M. (2022) · Andrology · doi:10.1111/andr.13183 · Cited by 13
Karl, M., Peterson-Yantorno, K., & Civan, M. M. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.09.007 · Cited by 11
“…AR receptors are well known to change adenylyl cyclase activity and intracellular cAMP concentration, but it is now well established that other pathways, such as phospholipase C (PLC), Ca2+ and mitogen-activated protein kinases, are relevant as well (Haas & Selbach, 2000; Jacobson & Gao, 2006).”
BackgroundPark, D., Yu, K. J., Cho, J. Y., Woo, S. B., Park, J., Lee, Z., & Kim, J. M. (2017) · Medicine · doi:10.1097/md.0000000000008741 · Cited by 12
van der Putten, C., Veth, J., Sukurova, L., Zuiderwijk-Sick, E. A., Simonetti, E. R., Koenen, H. J. P. M., Burm, S. M., van Noort, J. M., IJzerman, A. P., van Hijum, S. A. F. T., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800618 · Cited by 13
Penna, D. B. D. S., Raony, Í., Jardim-Messeder, D., dos Santos‐Rodrigues, A., & Pandolfo, P. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.114071 · Cited by 10
Choi, Y. J., Jeong, J. Y., & Hong, S. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c14492 · Cited by 10
Wixler, V., Boergeling, Y., Dantas, R. L., Varga, G., & Ludwig, S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01655-1 · Cited by 14
Hashimoto, A., & Hashimoto, S. (2024) · Cancers · doi:10.3390/cancers16234094 · Cited by 13
“Adenosine acts on purinergic receptors (A1, A2a, A2b, and A3), which regulate various physiological and pathological processes [198–200].”
Park, J.-S., Ma, Y., Wang, F., Ma, H., Sui, G.-Y., Rustamov, N., Han, M., Son, Y., Park, C., Han, S., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156114 · Cited by 12
Pečulis, R., Latkovskis, G., Tarāsova, L., Pīrāgs, V., Ērglis, A., & Kloviņš, J. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1230 · Cited by 10
“Hence, either this receptor is very efficiently coupled to the signaling pathways protecting the heart or the cardioprotective effects are also induced by activation of the A3R in cells outside cardiac tissues ( Jacobson and Gao, 2006).”
Banda, V., Chandrasekaran, B., Köse, M., Vielmuth, C., Müller, C. E., Kurumurthy, C., Gautham, S. K., Pillalamarri, S. R., Mailavaram, R. P., Akkinepally, R. R., et al. (2013) · Archiv der Pharmazie · doi:10.1002/ardp.201300003 · Cited by 10
Regionally selective cardiovascular responses to adenosine A 2A and A 2B receptor activation
Cooper, S. L., Wragg, E. S., Pannucci, P., Soave, M., Hill, S. J., & Woolard, J. (2022) · The FASEB Journal · doi:10.1096/fj.202101945r · Cited by 15
Pyrazin-2(1 H )-Ones as a Novel Class of Selective A3 Adenosine Receptor Antagonists
Azuaje, J., Carbajales, C., Gómez, M. A. G., Coelho, A., Caamaño, O., Gutiérrez‐de‐Terán, H., & Sotelo, E. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.69 · Cited by 10
New Insight Into A1 Adenosine Receptors in Diabetes Treatment
Wójcik, M., Zieleniak, A., & Woźniak, L. A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210794519066 · Cited by 10
“The stimulation of the A1 and A3ARs is associated with a decreased adenylyl cyclase activity through an activation of pertussis toxin-sensitive Gi proteins, although other adenosine receptor signaling pathways like protein kinase C (PKC), phosphoinositide 3 kinase (PI3K) and mitogen-activated protein kinases (MAPKs) f…”
BackgroundMustyala, K. K., Chitturi, A. R., J, P. S. N., & Vuruputuri, U. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.660532 · Cited by 10
“These physiological functions have been extensively reviewed (1,2).”
BackgroundMader, F., Krause, L., Tokay, T., Hakenberg, O. W., Köhling, R., & Kirschstein, T. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.137 · Cited by 10
Petrelli, R., Scortichini, M., Belardo, C., Boccella, S., Luongo, L., Capone, F., Kachler, S., Vita, P., Bello, F. D., Maione, S., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01399 · Cited by 10
Liang, D., Shao, H., Born, W. K., O’Brien, R. L., Kaplan, H. J., & Sun, D. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026150 · Cited by 12
Kanamori, T., MASAKI, Y., Oda, Y., Ohzeki, H., Ohkubo, A., Sekine, M., & Seio, K. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02747a · Cited by 10
Adenosine, Via A 2B Receptors, Inhibits Human (P-SMC) Progenitor Smooth Muscle Cell Growth
Dubey, R. K., Baruscotti, I., Stiller, R., Fingerle, J., Gillespie, D. G., Mi, Z., Leeners, B., Imthurn, B., Rosselli, M., & Jackson, E. K. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13698 · Cited by 11
“adenosine synthesis inhibitors, are under development for clinical use.(38,39) A 2B agonists are being developed to target cardiovascular disease(14); whereas, A 2B antagonists and CD73 inhibitors are being developed to target angiogenesis in cancer/tumors,(40,41) renal fi-”
van Rensburg, H. D. J., Legoabe, L. J., & Terre’Blanche, G. (2020) · Chemical Papers · doi:10.1007/s11696-020-01414-9 · Cited by 10
Reis, R. I., & Moraes, I. (2020) · Biology · doi:10.3390/biology9110400 · Cited by 10
CD73+ Dendritic Cells in Cascading Th17 Responses of Experimental Autoimmune Uveitis-Induced Mice
Ko, M. K., Shao, H., Kaplan, H. J., & Sun, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601272 · Cited by 11
Riff, R., Naamani, O., Mazar, J., Haviv, Y. S., Chaimovitz, C., & Douvdevani, A. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13607 · Cited by 10
Chapter 13 Recent Advances in Adenosine Receptor (AR) Ligands in Pulmonary Diseases
Kalla, R. V., & Zablocki, J. A. (2009) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(09)04413-3 · Cited by 10
Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A3 receptor ligands
Ravn, J., Qvortrup, K. M., Rosenbohm, C., & Koch, T. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.05.056 · Cited by 10
Nieto, M. I., Balo, C., Brea, J. M., Caamaño, O., Fernández, F., Xerardo Garcia-mera, B., López, C., Loza, M. I., Rodríguez-Borges, J. E., & Vidal, B. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.03.011 · Cited by 10
Block, & Cronstein, B. N. (2010) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s8860 · Cited by 10
“This may prove clinically relevant, as the components of the adenosine receptor signaling pathway provide new targets for drug development to treat hepatic fibrosis.(38) Furthermore, a role for adenosine receptors in fibrosis is not limited to the liver.”
Beattie, D., Brearley, A., Brown, Z., Charlton, S. J., Cox, B. J., Fairhurst, R. A., Fozard, J. R., Gedeck, P., Kirkham, P., Meja, K. K., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.131 · Cited by 10
New substituted 9-propyladenine derivatives as A 2A adenosine receptor antagonists
Lambertucci, C., Buccioni, M., Ben, D. D., Kachler, S., Marucci, G., Spinaci, A., Thomas, A., Klotz, K., & Volpini, R. (2015) · MedChemComm · doi:10.1039/c5md00034c · Cited by 10
Michael, S., Abdel-Aziz, H., Weiser, D., Müller, C. E., Kelber, O., & Nieber, K. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0714-y · Cited by 11
Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils
Sun, W., Moore, J. N., Hurley, D. J., Vandenplas, M. L., Linden, J. M., & Murray, T. F. (2007) · American Journal of Veterinary Research · doi:10.2460/ajvr.68.9.981 · Cited by 10
Caffeine Improves Heart Rate Without Improving Sepsis Survival
Bauzá, G., & Remick, D. G. (2015) · Shock · doi:10.1097/shk.0000000000000399 · Cited by 10
“Adenosine acting through its receptors is able to modulate cytokine and chemokine release and affect cell function (10).”
BackgroundSynthesis and Applications of Imidazoquinolines: A Review
Bazin, H. G., Bess, L. S., & Livesay, M. T. (2018) · Organic Preparations and Procedures International · doi:10.1080/00304948.2018.1433427 · Cited by 10
PET Imaging of Adenosine Receptors in Diseases
Li, J., Hong, X., Li, G., Conti, P. S., Zhang, X., & Chen, K. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190708163407 · Cited by 10
van Rensburg, H. D. J., Legoabe, L., Terre'Blanche, G., & Aucamp, J. (2019) · Bioorganic chemistry (Print) · doi:10.1016/j.bioorg.2019.103459 · Cited by 8
Synthesis of hybrid analogues of caffeine and eudistomin D and its affinity for adenosine receptors
Ishiyama, H., Nakajima, H., Nakata, H., & Kobayashi, J. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.036 · Cited by 10
Increased A3AR-dependent Vasoconstriction in Diabetic Mice Is Promoted by Myeloperoxidase
Nishat, S., Klinke, A., Baldus, S. E., Khan, L. A., & Basir, S. F. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000139 · Cited by 10
“Adenosine receptors are divided into 4 subtypes known as A1, A2A, A2B, and A3, which are members of the superfamily of G protein-coupled receptors and are most closely related to the receptors for biogenic amines.(4) Although there is a lot of evidence proving cardioprotective properties of the A3AR, 5 increased level…”
BackgroundTissue blood volumes and weights in adult beagle dogs.
Cuddihy, R. G., Hall, R. P., HOBBS, C. H., Boecker, B. B., & Muggenburg, B. A. (1972) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 10
Yet, L. (2018) · Wiley eBooks · doi:10.1002/9781118686263.ch3 · Cited by 10
Preti, B., Suchankova, A., Deganutti, G., Leuenberger, M., Barkan, K., Manulak, I., Huang, X., Carvalho, S., Ladds, G., & Lochner, M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01414 · Cited by 9
“Primary carboxamide derivative 18 was obtained from protected nitrile nucleoside 10 through hydrolysis with basic hydrogen peroxide in methanol at elevated temperatures.”
Seo, J.-H., Kim, W. K., Kang, K.-W., Lee, S., & Kang, B. (2024) · Journal of Veterinary Science · doi:10.4142/jvs.24147 · Cited by 10
“Considering that the adenosine receptor is a key target for inhibiting the inflammatory process [17], PDRN may be a promising substance for inflammation management in canine OA similar to humans.”
BackgroundAdenosine and adenosine receptors: a “double-edged sword” in cardiovascular system
Qian, Y., Zheng, Y., Leng, L., Liu, Q., Tian, X., Chen, S., Zhang, S., & Xie, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1538680 · Cited by 11
Elevated concentrations of plasma adenosine in obese children
Escudero, A. C., Carreño, B., Retamal, N., Celis, C., Castro, L., Aguayo, C. R., Acurio, J., & Escudero, C. (2012) · BioFactors · doi:10.1002/biof.1039 · Cited by 9
Ialenti, A., Caiazzo, E., Morello, S., Carnuccio, R., & Cicala, C. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244319 · Cited by 10
Adenosine A2A receptor as a potential target for improving cancer immunotherapy
Atif, M., Alsrhani, A., Naz, F., Ullah, M. I., Alameen, A. A. M., Imran, M., & Ejaz, H. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07685-7 · Cited by 9
“A1 receptors Adrenal gland, Brain (Hippocampus, Cerebellum, Cortex), spinal cord, atria, eye [37] Other regions of the brain adipose tissue, liver, kidney, skeletal muscles [37] Bronchi of lungs, Pancreas [37] Gi/o ↓ cAMP General, CHO Cellsa [3] ↑ Arachidonate (PLA2) ↑ IP3/DAG (PLC) [4, 5]”
BackgroundInfluentialHashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 11
MSClustering: A Cytoscape Tool for Multi-Level Clustering of Biological Networks
Ge, B.-K., Hu, G., Chen, R., & Chen, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214240 · Cited by 10
Kim, M., Choi, H., Nayak, A., Tripathi, S., Aswar, V. R., Gaikwad, V. B., Jacobson, K. A., & Jeong, L. S. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00344 · Cited by 9
Self-citationSynthesis and Binding Affinity of Homologated Adenosine Analogues as A3Adenosine Receptor Ligands
Lee, H. W., Choi, W. J., Jacobson, K. A., & Jeong, L. S. (2011) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2011.32.5.1620 · Cited by 9
Self-citationScatena, A., Fornai, F., Trincavelli, M. L., Taliani, S., Daniele, S., Pugliesi, I., Cosconati, S., Martini, C., & Settimo, F. D. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200036s · Cited by 9
Kuzhikandathil, E. V., Clark, L., & Li, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.268136 · Cited by 9
Anatomical Distribution of Nucleoside System in the Human Brain and Implications for Therapy
Kovács, Z., & Dobolyi, Á. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3903-5_29 · Cited by 13
Librán-Pérez, M., Velasco, C., Otero-Rodiño, C., López‐Patiño, M. A., Míguez, J. M., & Soengas, J. L. (2015) · Journal of Comparative Physiology B · doi:10.1007/s00360-015-0894-8 · Cited by 11
Biological Activities of Nucleosides and Their Analogues in Dietary Foods
Hu, G., & Yang, F. (2014) · Cited by 9
The Cholangiocyte Adenosine‐IL-6 Axis Regulates Survival During Biliary Cirrhosis
Lavoie, É. G., Fausther, M., Goree, J. R., & Dranoff, J. A. (2017) · Gene Expression · doi:10.3727/105221617x15042723767876 · Cited by 10
Do, H., Lee, J.-H., & Lim, J. (2018) · The Physician and Sportsmedicine · doi:10.1080/00913847.2018.1450059 · Cited by 10
“variety of cells in response to several types of stress [13].”
BackgroundJean, S., Hsueh, S.-C., Hwang, J., & Hsueh, P. (2019) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2019.06.004 · Cited by 9
Wang, H., Ma, Y., Wang, X., Zhang, W., Han, W., Liu, H., Li, M., Xiao, J., Wei, H., Wang, C., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114790 · Cited by 9
Metadata
- Authors
- Jacobson, K. A., & Gao, Z.-G.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Jacobson, Kenneth A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-03
- Volume
- 5
- Issue
- 3
- Pages
- 247-264
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3463109
- OpenAlex
- W1985598247
- Cited by
- 1,431
- References
- 215
- Citations by year
- 2026: 34 · 2025: 50 · 2024: 52 · 2023: 55 · 2022: 80 · 2021: 58 · 2020: 65 · 2019: 79 · 2018: 66 · 2017: 59 · 2016: 65 · 2015: 64 · 2014: 80 · 2013: 80 · 2012: 83
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK031117)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- adenosine receptors, adenosine receptor agonists, adenosine receptor antagonists, selective ligands, caffeine, cardiovascular disease, ischemic diseases, sleep disorders, inflammatory diseases, cancer, neurological disorders, drug development
- MeSH terms
- Animals, Disease, Drug Therapy, Humans, Ligands, Structure-Activity Relationship, Molecular Structure, Signal Transduction, Receptors, Purinergic P1, Purinergic P1 Receptor Agonists, Purinergic P1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.